Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Busse who wrote (13)	7/4/1996 3:41:00 PM
From: Sean Janzen	of 1501

Steve, Thanks for the E-mail. Very informative. I agree Inflazyme's greatest potential stems from the development of anti-inflammatory drugs. When I respond to other posts, i.e. TRIBY, that share a common theme such as diagnostic test kits, I often suggest readers look at the Inflazyme WEB page. So while the TB antigen plays a minuscule role in Inflazyme's potential, I like to use it to introduce the company to interested parties. It seems that readers of a particular post don't care to read about other companies. My feelings are quite the opposite. To find a company with the potential of IZP at such an early stage is rare and short lived. Have you taken a look at Micrologix Biotech or Trinity Biotech? If so, what are your thoughts? Is it time to start a MBI post? What part of North America are you from?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next